Intraocular injections of methotrexate have been used successfully to treat indeterminate and sarcoid uveitis as well as age-related macular degeneration. Methotrexate injection’s record of success in treating these inflammatory eye diseases prompted researchers to evaluate its efficacy in treating persistent diabetic macular edema.
